Clinical Trials Directory

Trials / Unknown

UnknownNCT03228069

Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults

Humoral and Cell-mediated Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in Previously Rabies Immunized HIV-infected Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Queen Saovabha Memorial Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To study the humoral and cell-mediated immune responses in HIV-infected adults who had previously received rabies booster vaccination more than a year before

Detailed description

Previous study has shown the higher immunogenicity response among HIV-infected adults who received a single visit 4-site intradermal rabies booster vaccination than those who received the conventional intramuscular regimen. The investigators follow the persistence of these effects. Also, the regulatory T cell levels were examined after the rabies booster vaccination .

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood drawn after rabies booster vaccinationBlood would be drawn for testing of rabies neutralizing antibody titers, rabies specific T lymphocytes and regulatory T cells after receipt of rabies booster vaccination at least a year before.

Timeline

Start date
2017-08-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2017-07-24
Last updated
2022-04-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03228069. Inclusion in this directory is not an endorsement.